The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine
Open accessAbstract
Introduction: Inflammatory bowel diseases (IBDs) are lifelong conditions causing relapsing inflammation of the intestine. In the absence of a cure, clinical management of IBDs is extremely challenging since they present with a wide range of phenotypes and disease behaviors. Hence, there is an urgent need for markers that could guide physicians in making the right choice of the rapidly growing treatment options toward a personalized care that could improve the overall outcome.Areas covered: In this review, the authors summarize existing biomarkers in IBD, discuss the challenges with the development of prognostic biomarkers and propose alternative options such as focusing on the prediction of the response to individual treatments, i.e. predictive biomarkers. The problems related to developing disease prognostic and predictive biomarkers in the field of IBDs are discussed including the difficulties in dealing with phenotypic heterogeneity particularly when performing studies in a real-life setting. The authors reviewed literature from PubMed.Expert opinion: Systems biology provides potential solutions to this problem by offering an unbiased, holistic approach to adjusting for variation in larger datasets thereby increasing the chances of identifying true associations between molecular profiles and clinical phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, an integrated approach can identify biomarkers, a long unmet need that can play a critical role in early diagnosis, predicting treatment response, and monitoring disease activity, progression, and recurrence.86”
From Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease (2024) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time
Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., & Ho, D. D. (1996) · Science · doi:10.1126/science.271.5255.1582 · Cited by 3,531 · cited 1×
“covery of viral dynamics in HIV-1 pathogenesis leading to modern combinatorial treatments [82].”
BackgroundUngaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,531
Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.12.031 · Cited by 2,911 · cited 1×
“recently by the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative aimed to define standardized treatment goals in adults [13] and children [14].”
BackgroundCytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706 · cited 1×
“min 25-OH D, antineutrophil cytoplasmic antibodies (ANCA), and (iii) components of the immune cascade such as cytokines and immune cells [63,64].”
BackgroundPeyrin-Biroulet, L., Sandborn, W., Sands, B. E., Reinisch, W., Bemelman, W., Bryant, R. V., D'Haens, G., Dotan, I., Dubinsky, M., Feagan, B., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.233 · Cited by 1,844 · cited 1×
“recently by the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative aimed to define standardized treatment goals in adults [13] and children [14].”
BackgroundThe Natural History of Adult Crohn's Disease in Population-Based Cohorts
Peyrin-Biroulet, L., Loftus, E. V., Colombel, J.-F., & Sandborn, W. J. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.579 · Cited by 1,047
Frolkis, A. D., Dykeman, J., Negrón, M. E., deBruyn, J., Jette, N., Fiest, K. M., Frolkis, T., Barkema, H. W., Rioux, K. P., Panaccione, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.041 · Cited by 892
Beaugerie, L., Seksik, P., Nion–Larmurier, I., Gendre, J., & Cosnes, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.019 · Cited by 860
Oxford IBD Cohort Investigators, West, N. R., Hegazy, A. N., Owens, B. M. J., Bullers, S. J., Linggi, B., Buonocore, S., Coccia, M., Görtz, D., This, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4307 · Cited by 811
Cytokine Networks in the Pathophysiology of Inflammatory Bowel Disease
Friedrich, M., Pohin, M., & Powrie, F. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.017 · Cited by 750 · cited 1×
“min 25-OH D, antineutrophil cytoplasmic antibodies (ANCA), and (iii) components of the immune cascade such as cytokines and immune cells [63,64].”
Background
Research works printed but not linked: 7
- Ye Y, 2020, Inflamm Bowel Dis, 26, 619
- Cesarini M, 2017, J Crohns Colitis, 11, 335
- Allez M, 2002, Am J Gastroenterol, 97, 947
- Fiorino G, 2017, J Crohns Colitis, 11, 274
- 10.1111/j.1572-0241.1998.00415.x · doi:10.1111/j.1572-0241.1998.00415.x · Paper page
- Reinisch W, 2017, J Crohns Colitis, 11, 425
- Ventin-Holmberg R, 2020, J Crohns Colitis
Cited by
Iacucci, M., Santacroce, G., Zammarchi, I., Maeda, Y., Del Amor, R., Meseguer, P., Kolawole, B. B., Chaudhari, U., Di Sabatino, A., Danese, S., et al. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00053-0 · Cited by 73
Magalhães, D., Peyrin‐Biroulet, L., Estevinho, M. M., Danese, S., & Magro, F. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231155987 · Cited by 15
“Studies were excluded if met any of the following criteria: (1) did not refer to human studies; (2) did not refer to IBD; (3) were reviews, book chapters, guidelines, editorials, case reports, or comments; (4) had full text in languages other than English, Spanish, or Portuguese; (5) did not refer to neutrophil-relate…”
BackgroundMinea, H. O., Sîngeap, A.-M., Minea, M., Juncu, S. S., Muzica, C. M., Sfarti, C. V., Gîrleanu, I., Chiriac, S. A., Miftode, D., Stanciu, C., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158420 · Cited by 14
“Recently, it has been reported that various treatment options are only effective in approximately 40–60% of individuals because of molecular mechanisms involved in the modulation of intestinal inflammation [7,8].”
BackgroundGovindarasu, M., Vaiyapuri, M., & Kim, J. (2024) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-024-03047-8 · Cited by 9
“Pathophysi-ological indicators have not yet been able to accurately predict IBD treatment outcomes [16, 17].”
Vuijk, S. A., & de Ridder, L. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17243
Metadata
- Authors
- Giachero, F., Jenke, A., & Zilbauer, M.
- Affiliations
- Witten/Herdecke University (DE)
- Corresponding author
- Zilbauer, Matthias
- Venue
- Expert Review of Clinical Immunology
- Publisher
- Informa UK Limited
- Published
- 2021-06-28
- Volume
- 17
- Issue
- 8
- Pages
- 871-881
- ISSN
- 1744-666X (ISSN-L)
- 1744-8409
- PMC
- PMC8903817
- OpenAlex
- W3170116140
- Cited by
- 7
- References
- 100
- Citations by year
- 2026: 1 · 2024: 4 · 2023: 1 · 2022: 1
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Expert Review of Clinical Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Medical Research Council MRC UK (RPAG/214)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- inflammatory bowel disease, prognostic factors, predictive biomarkers, systems biology, disease outcome prediction, phenotypic heterogeneity, personalized medicine, treatment response prediction, molecular profiles
- MeSH terms
- Humans, Prognosis, Systems Analysis, Inflammatory Bowel Diseases, Biomarkers, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine. https://app.cochat.ai/papers/10.1080/1744666x.2021.1945442
- The paper
- Giachero, F., Jenke, A., & Zilbauer, M. (2021). Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine. Expert Review of Clinical Immunology. https://doi.org/10.1080/1744666x.2021.1945442
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

